ES548492A0 - Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion - Google Patents

Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion

Info

Publication number
ES548492A0
ES548492A0 ES548492A ES548492A ES548492A0 ES 548492 A0 ES548492 A0 ES 548492A0 ES 548492 A ES548492 A ES 548492A ES 548492 A ES548492 A ES 548492A ES 548492 A0 ES548492 A0 ES 548492A0
Authority
ES
Spain
Prior art keywords
preparation
lyophilization
procedure
dry substances
substances obtainable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548492A
Other languages
English (en)
Other versions
ES8701491A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES548492A0 publication Critical patent/ES548492A0/es
Publication of ES8701491A1 publication Critical patent/ES8701491A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
  • Magnetic Record Carriers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
ES548492A 1984-11-06 1985-11-04 Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion Expired ES8701491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530584 1984-11-06

Publications (2)

Publication Number Publication Date
ES548492A0 true ES548492A0 (es) 1986-12-01
ES8701491A1 ES8701491A1 (es) 1986-12-01

Family

ID=4291364

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548492A Expired ES8701491A1 (es) 1984-11-06 1985-11-04 Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion

Country Status (26)

Country Link
US (1) US5002940A (es)
EP (2) EP0181287B1 (es)
JP (2) JPS61204118A (es)
KR (1) KR890000907B1 (es)
AT (2) ATE51152T1 (es)
AU (2) AU586988B2 (es)
CA (1) CA1249223A (es)
CY (2) CY1898A (es)
DD (1) DD244292A5 (es)
DE (2) DE3587020D1 (es)
DK (1) DK162510C (es)
ES (1) ES8701491A1 (es)
FI (1) FI85809C (es)
GR (1) GR852637B (es)
HK (2) HK101192A (es)
HU (1) HU195728B (es)
IE (2) IE63156B1 (es)
IL (1) IL76943A (es)
MX (1) MX9203371A (es)
NL (1) NL940015I2 (es)
NO (1) NO169324C (es)
NZ (2) NZ214069A (es)
PH (1) PH21673A (es)
PT (1) PT81429B (es)
SG (1) SG107192G (es)
ZA (1) ZA858481B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH673395A5 (es) * 1987-01-30 1990-03-15 Ciba Geigy Ag
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
WO2000033817A1 (en) * 1998-12-08 2000-06-15 Phares Pharmaceutical Research N.V. Phospholipid compositions
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
US6487907B1 (en) * 1999-07-08 2002-12-03 California Institute Of Technology Microgyroscope with integrated vibratory element
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
EP2185112A4 (en) * 2007-08-21 2012-01-18 Harbor Biosciences Inc STABILIZED THERAPEUTIC COMPOSITIONS AND FORMULATIONS
WO2019213286A1 (en) * 2018-05-02 2019-11-07 LifeMax Laboratories, Inc. Extended release suspension formulation of lurasidone

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068447A1 (en) * 1969-11-26 1971-08-27 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
LU77457A1 (es) * 1977-05-31 1979-01-19
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
DE3339295A1 (de) * 1982-11-15 1984-05-17 Schering AG, 1000 Berlin und 4709 Bergkamen 4-hydroxy- und 4-acyloxy-4-androsten-3,17-dione zur verwendung bei der prophylaxe und therapie der prostatahyperplasie und diese enthaltende mittel fuer derartige verwendung
EP0117811A3 (fr) * 1983-02-23 1987-06-03 Sanofi S.A. Compositions pharmaceutiques antifongiques utilisables par voie orale
EP0226021A1 (de) * 1985-12-12 1987-06-24 BBC Brown Boveri AG Thyristor mit schaltbarem Emitter-Kurzschluss

Also Published As

Publication number Publication date
NZ229276A (en) 1989-08-29
HK101192A (en) 1992-12-24
CY1677A (en) 1993-10-10
EP0181287B1 (de) 1990-03-21
AU4934485A (en) 1986-05-15
NL940015I1 (nl) 1994-10-17
IE902490L (en) 1986-05-06
EP0181287A2 (de) 1986-05-14
PH21673A (en) 1988-01-13
FI854330A (fi) 1986-05-07
NO854403L (no) 1986-05-07
AU586988B2 (en) 1989-08-03
ATE51152T1 (de) 1990-04-15
GR852637B (es) 1986-03-04
EP0181287A3 (en) 1987-09-23
CA1249223A (en) 1989-01-24
DK509485D0 (da) 1985-11-05
HUT42936A (en) 1987-09-28
HU195728B (en) 1988-07-28
JPH0558410B2 (es) 1993-08-26
AU633844B2 (en) 1993-02-11
FI85809C (fi) 1992-06-10
EP0346953B1 (de) 1993-01-20
IE63156B1 (en) 1995-03-22
KR860003825A (ko) 1986-06-13
DK162510B (da) 1991-11-11
DE3576650D1 (de) 1990-04-26
DK162510C (da) 1992-03-30
FI85809B (fi) 1992-02-28
NO169324B (no) 1992-03-02
ES8701491A1 (es) 1986-12-01
NO169324C (no) 1992-06-10
ZA858481B (en) 1986-06-25
PT81429B (pt) 1988-03-03
AU4150489A (en) 1990-01-04
ATE84718T1 (de) 1993-02-15
IL76943A (en) 1990-02-09
HK192095A (en) 1995-12-29
NZ214069A (en) 1989-08-29
EP0346953A3 (en) 1990-11-22
EP0346953A2 (de) 1989-12-20
JPH0768130B2 (ja) 1995-07-26
DD244292A5 (de) 1987-04-01
DK509485A (da) 1986-05-07
PT81429A (en) 1985-12-01
US5002940A (en) 1991-03-26
IE63166B1 (en) 1995-03-22
JPS61204118A (ja) 1986-09-10
SG107192G (en) 1992-12-24
CY1898A (en) 1985-10-31
JPH0648945A (ja) 1994-02-22
FI854330A0 (fi) 1985-11-04
MX9203371A (es) 1992-09-01
IE852755L (en) 1986-05-06
NL940015I2 (nl) 1997-01-06
DE3587020D1 (de) 1993-03-04
KR890000907B1 (ko) 1989-04-13

Similar Documents

Publication Publication Date Title
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
DK183386D0 (da) Sucralfatsuspension
ES541657A0 (es) Perfeccionamientos en la fabricacion de envolventes de frag-mentacion para proyectiles
ES548492A0 (es) Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion
ES543146A0 (es) Procedimiento para la obtencion de derivados trifenilmetili-cos de la snglicero-3-fosfocolina y sn-glicero-3-fosfoetano-lamina
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
ES526132A0 (es) Un procedimiento para la preparacion de una composicion cosmetica.
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
FR2543435B1 (fr) Composition antimycosique sous forme de creme au bifonazole, a forte liberation de substance active
RO95350A2 (ro) Procedeu de obtinere a unei compozitii medicamentoase solide

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20060919